1. Home
  2. CCB vs NNNN Comparison

CCB vs NNNN Comparison

Compare CCB & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coastal Financial Corporation

CCB

Coastal Financial Corporation

N/A

Current Price

$113.82

Market Cap

1.5B

Sector

Finance

ML Signal

N/A

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

N/A

Current Price

$32.30

Market Cap

1.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CCB
NNNN
Founded
1997
2021
Country
United States
Germany
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
2018
2025

Fundamental Metrics

Financial Performance
Metric
CCB
NNNN
Price
$113.82
$32.30
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$117.50
N/A
AVG Volume (30 Days)
111.3K
27.3K
Earning Date
01-27-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
6.19
N/A
EPS
3.17
0.06
Revenue
$343,667,000.00
$8,185,146.00
Revenue This Year
$85.02
N/A
Revenue Next Year
$17.38
N/A
P/E Ratio
$36.31
$518.11
Revenue Growth
26.18
21.95
52 Week Low
$76.11
$5.18
52 Week High
$119.58
$55.65

Technical Indicators

Market Signals
Indicator
CCB
NNNN
Relative Strength Index (RSI) 54.97 56.49
Support Level $113.78 $26.06
Resistance Level $119.58 $44.73
Average True Range (ATR) 4.08 6.09
MACD 0.22 -0.20
Stochastic Oscillator 54.36 50.51

Price Performance

Historical Comparison
CCB
NNNN

About CCB Coastal Financial Corporation

Coastal Financial Corp is a bank holding company. Through its subsidiaries, the company conducts its business in three reportable segments which include, Community Bank, CCBX, and Treasury and Administration. The Community Bank segment includes all community banking activities, with a primary focus on providing various banking products and services to consumers and small to medium-sized businesses. The CCBX segment provides Banking as a Service (BaaS) that allows its broker dealers and digital financial service partners to offer their customers banking services, and the Treasury and administration segment includes treasury management, overall administration, and all other aspects of the company. The maximum revenue of the company is generated from the CCBX segment.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: